Search results for "PULMONARY"

showing 10 items of 3030 documents

Fever and dyspnoea in a tracheostomised patient

2020

A 65-year-old man was referred for evaluation of acute onset of fever, productive cough and dyspnoea. He had previously received a diagnosis of laryngeal carcinoma, which had been treated with laryngectomy and bilateral laterocervical lymphadenectomy, followed by chemotherapy. He underwent plastic surgery of the laryngocutaneous fistula, and a positron emission tomography (PET)- computed tomography (CT) examination performed during follow-up showed 18-FDG (2-fluoro-2-deoxyd- glucose) lung uptake in the apical right portion. He had a smoking history and his regular medications included dexamethasone, metoclopramide, omeprazole, furosemide, cholecalciferol and pregabalin. He had a history of …

lcsh:RC705-779Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrylung fibrosisMEDLINECase Reportlcsh:Diseases of the respiratory systemtomographySettore MED/10 - Malattie Dell'Apparato RespiratorioExpert Opinionoilrespiratory tract diseases18Emergency medicineMedicinebusiness
researchProduct

Liquid Phase Micro-Extraction of Linear Alkylbenzene Sulfonate Anionic Surfactants in Aqueous Samples

2011

Hollow fiber liquid phase micro-extraction (LPME) of linear alkylbenzene sulfonates (LAS) from aqueous samples was studied. Ion pair extraction of C10, C11, C12 and C13 homologues was facilitated with trihexylamine as ion-pairing agent, using di-n-hexylether as solvent for the supported liquid membrane (SLM). Effects of extraction time, acceptor buffer concentration, stirring speed, sample volume, NaCl and humic acids were studied. At 10–50 µg L−1 linear R2-coefficients were 0.99 for C10 and C11 and 0.96 for C12. RSD was typically ~15%. Three observations were especially made. Firstly, LPME for these analytes was unusually slow with maximum enrichment observed after 15–24 h (depending on sa…

linear alkylbenzene sulfonateLinear alkylbenzenesurfactantFiltration and Separationlcsh:Chemical technologyArticleion-pairingchemistry.chemical_compoundPulmonary surfactantMass transferChemical Engineering (miscellaneous)lcsh:TP1-1185lcsh:Chemical engineeringchemistry.chemical_classificationAqueous solutionChromatographyChemistryProcess Chemistry and TechnologyExtraction (chemistry)lcsh:TP155-156SolventMembranelinear alkylbenzene sulfonate; extraction; liquid-phase microextraction; ion-pairing; method development; environmental analysis; surfactantenvironmental analysisextractionliquid-phase microextractionmethod developmentCounterionMembranes
researchProduct

Composition influence on pulmonary delivery of rifampicin liposomes.

2012

The effects of lipid concentration and composition on the physicochemical properties, aerosol performance and in vitro toxicity activity of several rifampicin-loaded liposomes were investigated. To this purpose, six liposome formulations containing different amounts of soy phosphatidylcholine and hydrogenated soy phosphatidylcholine, with and without cholesterol and oleic acid, were prepared and fully characterized. Uni- or oligo-lamellar, small (~100 nm), negatively charged (~60 mV) vesicles were obtained. Lipid composition affected aerosol delivery features of liposomal rifampicin; in particular, the highest phospholipid concentration led to a better packing of the vesic…

liposomesaerosolPhospholipidpulmonary deliveryPharmaceutical Sciencelcsh:RS1-441liposomes; rifampicin; cholesterol; oleic acid; rheology; pulmonary delivery; aerosol; cell viability; cellular uptakerifampicinArticlelcsh:Pharmacy and materia medicachemistry.chemical_compoundPhosphatidylcholineMedicinecell viabilityLiposomeChromatographyCholesterolbusiness.industryVesiclecholesterolcellular uptakeIn vitroOleic acidchemistryBiochemistryoleic acidToxicitylipids (amino acids peptides and proteins)rheologybusinessPharmaceutics
researchProduct

Preprocessing methods for nodule detection in lung CT

2005

Abstract The use of automatic systems in the analysis of medical images has proven to be very useful to radiologists, especially in the framework of screening programs, in which radiologists make their first diagnosis on the basis of images only, most of those corresponding to healthy patients, and have to distinguish pathological findings from non-pathological ones at an early stage. In particular, we are developing preprocessing methods to be applied for pulmonary nodule Computer Aided Detection in low-dose lung Multi Slice CT (computed tomography) images.

low-dose lung MSCTNodule detectionmedicine.medical_specialtylung nodules detectionmedicine.diagnostic_testbusiness.industryComputed tomographyGeneral MedicineComputer aided detectionlow-dose lung MSCT; lung nodules detectionMulti slice ctLow dose lung MSCTPulmonary noduleScreening programsMedicinePreprocessorlung nodule detectionRadiologyStage (cooking)businessInternational Congress Series
researchProduct

Associations between muscle strength, spirometric pulmonary function and mobility in healthy older adults

2014

Background: Pathological obstruction in lungs leads to severe decreases in muscle strength and mobility in patients suffering from chronic obstructive pulmonary disease. The purpose of this study was to investigate the interdependency between muscle strength, spirometric pulmonary functions and mobility outcomes in healthy older men and women, where skeletal muscle and pulmonary function decline without interference of overt disease. Methods: 135 69 to 81‐yr‐old participants were recruited into the cross‐sectional study, which was performed as a part of European study MyoAge. Full, partial and no mediation models were constructed to assess the interdependency between muscle strength (handgr…

lower extremity muscle powertimed up and go testhandgrip strengthsix-minute walk testspirometriaspirometric pulmonary functionknee extension torque
researchProduct

Comorbidities and clinical outcomes of a lung cancer screening trial participants with chronic obstructive pulmonary disease in three-year follow-up

2022

To improve the effectiveness of lung cancer screening using low-dose computed tomography (LDCT), the presence of smoking-related comorbidities that may significantly affect mortality in this group should be taken into account. Material and methods: A questionnaire survey and spirometry tests were conducted in a group of 730 respondents as part of a lung cancer screening study between 2016 and 2018. People diagnosed with COPD underwent a three-year follow-up to assess the incidence of medical events. Results: Our study confirmed that cardiovascular diseases (CVDs) were the most common comorbidities in patients who were diagnosed with COPD and participated in LDCT lung cancer screening. Among…

lung cancerscreeningoncologydiagnostic radiologyGeneral Medicinerespiratory tractchronic obstructive pulmonary diseaseEuropean Journal of Translational and Clinical Medicine
researchProduct

Noninvasive Ventilation in Critically Ill Patients

2015

Since its first application in the late 1980s, noninvasive ventilation (NIV) has been the first-line intervention for certain forms of acute respiratory failure. NIV may be delivered through the patient's mouth, nose, or both using noninvasive intermittent positive pressure ventilation or continuous positive airway pressure. When applied appropriately, NIV may reduce morbidity and mortality and may avert iatrogenic complications and infections associated with invasive mechanical ventilation. This article provides physicians and respiratory therapists with a comprehensive, practical guideline for using NIV in critical care. © 2015 Elsevier Inc.

lung diseaseproceduremedicine.medical_treatmenttreatment indicationtreatment contraindicationReviewCritical Care and Intensive Care MedicineAcute respiratory failureintensive care unitequipment designContinuous positive airway pressureHospital MortalityRespiratory systemNoserisk reductionsleep disorderemergency health serviceRespiratory Distress Syndromeemergency wardcritical illnehumidifierGeneral Medicineadult respiratory distress syndromeIntermittent positive pressure ventilationCritically patientrespiratory circuitmedicine.anatomical_structurepriority journalpositive end expiratory pressureNoninvasive ventilationEmergency Service Hospitalmedicine.medical_specialtyventilatorCritical Illnesswardhypercapnic nonchronic obstructive pulmonary diseasecritically ill patientRespiratory Distress Syndrome Adult Critical Illneobesity hypoventilation syndromemedicineHumansAcute respiratory failurehumanIntensive care medicinelung edemaMechanical ventilationgeneral wardhypoxemiaNoninvasive Ventilationair humidificationCritically illbusiness.industrypractice guidelineRespiratory Distress Syndrome Adultneurally adjusted ventilator assistrespiratory intensive care unitmortalityacute cardiogenic pulmonary edemahypercapnic chronic obstructive pulmonary diseasedisease exacerbationnoninvasive positive pressure ventilationbusinesschronic obstructive lung diseaserespiratory therapeutic device
researchProduct

Expertise préalable à la création d’un tableau de maladie professionnelle ou à l’élaboration de recommandations aux comités régionaux dereconnaissanc…

2022

Le plan d’actions sur les produits phytopharmaceutiques publié en avril 2018 vise notamment, sur la base des recommandations formulées par l’Inspection générale des affaires sociales, l’Inspection générale des finances et le Conseil général de l’alimentation, de l’agriculture etdes espaces ruraux dans leur rapport conjoint de janvier 2018, à améliorer la prise en charge des maladies professionnelles liées aux pesticides.Dans ce cadre, les pouvoirs publics ont, par courrier en date du 24 avril 2018, saisi l’Institut national de la santé et de la recherche médicale (Inserm) afin d’actualiser l’expertise collective « Pesticides : effets sur la santé » parue en 2013. Cette expertise synthétise …

medical diagnosis[SDV]Life Sciences [q-bio]causal relationshipreconnaissanceOccupational diseaseoccupational exposurepesticidesMaladie professionnellechronic obstructive pulmonary diseasecompensationexposition professionnelle[SDV] Life Sciences [q-bio]diagnostic médical[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBronchopneumopathie chronique obstructive[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologierelation causale
researchProduct

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition.

2021

Abstract Direct oral anti–activated factor X and antithrombin agents have largely replaced vitamin K antagonists as the standard of care in treatment of venous thromboembolism. However, gaps in efficacy and safety persist, notably in end‐stage renal disease, implantable heart valves or assist devices, extracorporeal support of the circulation, and antiphospholipid syndrome. Inhibition of coagulation factor XI (FXI) emerges as a promising new therapeutic target. Antisense oligonucleotides offer potential advantages as a prophylactic or therapeutic modality, with one dose‐finding trial in orthopedic surgery already published. In addition, monoclonal antibodies blocking activation and/or activ…

medicine.drug_class2720 Hematologyvenous thromboembolism610 Medicine & healthBioinformaticslaw.inventionchemistry.chemical_compoundRandomized controlled trialAntiphospholipid syndromelawAntithromboticMedicineDiseases of the blood and blood-forming organsFactor XIIbusiness.industrycatheter(s)Factor X10031 Clinic for AngiologyAntithrombinAnticoagulantanticoagulantHematologycontact systemmedicine.diseasefactor XIPulmonary embolismchemistryRC633-647.5businessState of the Art Isth 2020medicine.drugResearch and practice in thrombosis and haemostasis
researchProduct

Treatment of pulmonary embolism.

2015

International audience; The treatment of pulmonary embolism is going to be deeply modified by the development of Direct Oral Anticoagulants (DOACs). There are currently three anti-Xa factors (rivaroxaban, apixaban, edoxaban) and one anti-IIa factor (dabigatran) labeled by the FDA and the EMA. All these drugs are direct anticoagulant, orally effective, without the need for adaptation to hemostasis test. As kidney excretion is involved for all of them, they are contra-indicated in patients with severe renal failure (creatinine clearance<30mL/min according to Cockcroft & Gault formula). All the anti-Xa factor drugs are metabolized by liver cytochromes and then contra-indicated in case of liver…

medicine.drug_classPyridinesPyridones[SDV]Life Sciences [q-bio]PopulationRenal functionRisk AssessmentAntithrombinsDabigatranchemistry.chemical_compoundRivaroxaban[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemEdoxaban[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyMedicineHumanseducationeducation.field_of_studyRivaroxabanClinical Trials as Topic[ SDV ] Life Sciences [q-bio]business.industryMedicine (all)AnticoagulantGeneral MedicineVenous Thromboembolism[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease3. Good healthPulmonary embolismDabigatranThiazolesAntithrombins; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Venous Thromboembolism; Medicine (all)chemistryAnesthesiaPyrazolesApixabanbusinessPulmonary Embolism[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drugFactor Xa Inhibitors
researchProduct